Velez MA - Search Results

1

Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.

Speirs CK, DeWees TA, Rehman S, Molotievschi A, Velez MA, Mullen D, Fergus S, Trovo M, Bradley JD, Robinson CG. Speirs CK, et al. Among authors: velez ma. J Thorac Oncol. 2017 Feb;12(2):293-301. doi: 10.1016/j.jtho.2016.09.134. Epub 2016 Oct 12. J Thorac Oncol. 2017. PMID: 27743888 Free article. Clinical Trial.

2

Tolerance of the Brachial Plexus to High-Dose Reirradiation.

Chen AM, Yoshizaki T, Velez MA, Mikaeilian AG, Hsu S, Cao M. Chen AM, et al. Among authors: velez ma. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):83-90. doi: 10.1016/j.ijrobp.2017.01.244. Epub 2017 Feb 7. Int J Radiat Oncol Biol Phys. 2017. PMID: 28587056

3

Re-irradiation for recurrent and second primary cancers of the head and neck.

Velez MA, Veruttipong D, Wang PC, Chin R, Beron P, Abemayor E, St John M, Chen AM. Velez MA, et al. Oral Oncol. 2017 Apr;67:46-51. doi: 10.1016/j.oraloncology.2017.01.007. Epub 2017 Feb 7. Oral Oncol. 2017. PMID: 28351580

4

Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC.

Zhou N, Velez MA, Bachrach B, Gukasyan J, Fares CM, Cummings AL, Lind-Lebuffe JP, Akingbemi WO, Li DY, Brodrick PM, Yessuf NM, Rettinger S, Grogan T, Rochigneux P, Goldman JW, Garon EB, Lisberg A. Zhou N, et al. Among authors: velez ma. Lung Cancer. 2021 Nov;161:34-41. doi: 10.1016/j.lungcan.2021.08.009. Epub 2021 Aug 30. Lung Cancer. 2021. PMID: 34507111 Free PMC article.

5

What is the current role of immunotherapy in EGFR mutant advanced NSCLC?

Velez MA, Tsai HHC, Shackelford DB, Garon EB, Lisberg A. Velez MA, et al. Lung Cancer. 2022 Apr;166:253-254. doi: 10.1016/j.lungcan.2021.12.001. Epub 2021 Dec 24. Lung Cancer. 2022. PMID: 35031176 No abstract available.

6

Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.

Velez MA, Wang PC, Hsu S, Chin R, Beron P, Abemayor E, St John M, Chen AM. Velez MA, et al. Am J Otolaryngol. 2018 May-Jun;39(3):257-260. doi: 10.1016/j.amjoto.2018.01.011. Epub 2018 Feb 7. Am J Otolaryngol. 2018. PMID: 29433815

7

FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.

Velez MA, Veruttipong D, Wang PC, Abemayor E, St John M, TenNapel M, Chen AM. Velez MA, et al. Laryngoscope. 2018 Oct;128(10):2345-2350. doi: 10.1002/lary.27173. Epub 2018 Mar 24. Laryngoscope. 2018. PMID: 29573279

8

Comparison of patient-reported acute urinary and sexual toxicity scores in a 6- versus 2-fraction course of high-dose-rate prostate brachytherapy monotherapy.

Ragab O, Banerjee R, Park SJ, Patel S, Zhang M, Wang J, Velez M, Demanes DJ, Kamrava M. Ragab O, et al. J Med Imaging Radiat Oncol. 2018 Feb;62(1):109-115. doi: 10.1111/1754-9485.12648. Epub 2017 Aug 29. J Med Imaging Radiat Oncol. 2018. PMID: 28856847

9

The estrogen pathway as a modulator of response to immunotherapy.

Velez MA, Burns TF, Stabile LP. Velez MA, et al. Immunotherapy. 2019 Sep;11(13):1161-1176. doi: 10.2217/imt-2019-0024. Epub 2019 Jul 30. Immunotherapy. 2019. PMID: 31361169 Review.

10

Immunologic mediators of outcome for irradiated oropharyngeal carcinoma based on human papillomavirus status.

Meshman J, Velez MA, Wang PC, Abemayor E, St John M, Wong D, Bhuta S, Chen AM. Meshman J, et al. Among authors: velez ma. Oral Oncol. 2019 Feb;89:121-126. doi: 10.1016/j.oraloncology.2018.11.030. Epub 2019 Jan 4. Oral Oncol. 2019. PMID: 30732949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters